Century Therapeutics, Inc.: Regulation FD disclosure and EASD presentation

What happened Century Therapeutics, Inc. announced that nonclinical data from its iPSC-derived cell therapy platform was presented at the European Association for the Study of Diabetes (EASD) held on Oct 2, 2026 in Milan, Italy. The company issued a press release and furnished it as Exhibit 99.1 to the Form 8-K. The company also furnished presentation slides as Exhibit 99.2 and stated it undertakes no obligation to update the materials.

Key details

• Date of presentation: Oct 2, 2026; location: Milan, Italy.
• Topic: nonclinical data from the company’s iPSC-derived cell therapy platform.
• Filing items reported: Item 7.01 (Regulation FD disclosure) and Item 8.01 (Other events).
• Exhibits furnished: Exhibit 99.1 (press release) and Exhibit 99.2 (EASD presentation slides).

Why it may matter Item 7.01 (Regulation FD disclosure) covers public release of material information via a press release. Item 8.01 (Other events) covers the company furnishing additional materials related to the presentation. The filing does not show why the insider traded or why the company acted.